Literature DB >> 17266934

Mutations in the Kv1.5 channel gene KCNA5 in cardiac arrest patients.

Nathalie H Nielsen1, Bo G Winkel, Jørgen K Kanters, Nicole Schmitt, Jacob Hofman-Bang, Henrik S Jensen, Bo H Bentzen, Bjarne Sigurd, Lars A Larsen, Paal S Andersen, Stig Haunsø, Keld Kjeldsen, Morten Grunnet, Michael Christiansen, Søren-Peter Olesen.   

Abstract

Mutations in one of the ion channels shaping the cardiac action potential can lead to action potential prolongation. However, only in a minority of cardiac arrest cases mutations in the known arrhythmia-related genes can be identified. In two patients with arrhythmia and cardiac arrest, we identified the point mutations P91L and E33V in the KCNA5 gene encoding the Kv1.5 potassium channel that has not previously been associated with arrhythmia. We functionally characterized the mutations in HEK293 cells. The mutated channels behaved similarly to the wild-type with respect to biophysical characteristics and drug sensitivity. Both patients also carried a D85N polymorphism in KCNE1, which was neither found to influence the Kv1.5 nor the Kv7.1 channel activity. We conclude that although the two N-terminal Kv1.5 mutations did not show any apparent electrophysiological phenotype, it is possible that they may influence other cellular mechanisms responsible for proper electrical behaviour of native cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266934     DOI: 10.1016/j.bbrc.2007.01.048

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Systems pharmacology of arrhythmias.

Authors:  Seth I Berger; Avi Ma'ayan; Ravi Iyengar
Journal:  Sci Signal       Date:  2010-04-20       Impact factor: 8.192

2.  Myriad roles of voltage-activated potassium channel subunit Kvβ1.1 in the heart.

Authors:  Rakesh C Kukreja
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-01-27       Impact factor: 4.733

3.  18β-Glycyrrhetinic acid preferentially blocks late Na current generated by ΔKPQ Nav1.5 channels.

Authors:  Yi-mei Du; Cheng-kun Xia; Ning Zhao; Qian Dong; Ming Lei; Jia-hong Xia
Journal:  Acta Pharmacol Sin       Date:  2012-05-21       Impact factor: 6.150

4.  LQT5 masquerading as LQT2: a dominant negative effect of KCNE1-D85N rare polymorphism on KCNH2 current.

Authors:  Eyal Nof; Hector Barajas-Martinez; Michael Eldar; Janire Urrutia; Gabriel Caceres; Gail Rosenfeld; David Bar-Lev; Micha Feinberg; Elena Burashnikov; Oscar Casis; Dan Hu; Michael Glikson; Charles Antzelevitch
Journal:  Europace       Date:  2011-06-28       Impact factor: 5.214

5.  Loperamide Toxicity Revealing Apical Hypertrophic Cardiomyopathy.

Authors:  Najah Khan; Kalyan R Chitturi; Courtney Hatcher; Marietta Clewing; Sherif F Nagueh
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-03-25

Review 6.  The genetics of drug-induced QT prolongation: evaluating the evidence for pharmacodynamic variants.

Authors:  Ana I Lopez-Medina; Choudhary Anwar A Chahal; Jasmine A Luzum
Journal:  Pharmacogenomics       Date:  2022-06-14       Impact factor: 2.638

7.  Next-generation sequencing of 100 candidate genes in young victims of suspected sudden cardiac death with structural abnormalities of the heart.

Authors:  C L Hertz; S L Christiansen; L Ferrero-Miliani; M Dahl; P E Weeke; G L Ottesen; R Frank-Hansen; H Bundgaard; N Morling
Journal:  Int J Legal Med       Date:  2015-09-17       Impact factor: 2.686

Review 8.  Oxidative modulation of voltage-gated potassium channels.

Authors:  Nirakar Sahoo; Toshinori Hoshi; Stefan H Heinemann
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

Review 9.  KCNE1 and KCNE3: The yin and yang of voltage-gated K(+) channel regulation.

Authors:  Geoffrey W Abbott
Journal:  Gene       Date:  2015-09-26       Impact factor: 3.688

10.  KCNE1 D85N polymorphism--a sex-specific modifier in type 1 long QT syndrome?

Authors:  Annukka M Lahtinen; Annukka Marjamaa; Heikki Swan; Kimmo Kontula
Journal:  BMC Med Genet       Date:  2011-01-18       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.